Amplification of the epidermal growth factor receptor (EGFR) gene, mutations in the IDH1 and IDH2 genes, and loss of tumor suppressor genes such as TP53 and PTEN serve as the most identified genetic abnormalities in GBM (7). The gene discussed is PTEN; the disease is glioblastoma.